Cryo-electron microscopy study of insect cell-expressed enterovirus 71 and coxsackievirus A16 Virus-like particles provides a structural basis for vaccine development

Journal of Virology

Volumn 88, Issue 11, 2014, Pages 6444-6452

  Gong, Minqing ^a,c   Zhu, Hongtao ^a,c   Zhou, Jun ^b   Yang, Chunting ^b   Feng, Jing ^b   Huang, Xiaojun ^a   Ji, Gang ^a   Xu, Honglin ^b   Zhu, Ping ^a  

^a INSTITUTE OF BIOPHYSICS   (China)

^b Department of Virology National Vaccine and Serum Institute ^*  (China)

^c UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM POTASSIUM SULFATE; COXSACKIE VIRUS A16 VACCINE; CPG OLIGODEOXYNUCLEOTIDE; ENTEROVIRUS 71 VACCINE; EPITOPE; IMMUNOLOGICAL ADJUVANT; NEUTRALIZING ANTIBODY; UNCLASSIFIED DRUG; VIRUS LIKE PARTICLE VACCINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BACULOVIRUS; CONTROLLED STUDY; COXSACKIE VIRUS A; COXSACKIE VIRUS A16; CRYOELECTRON MICROSCOPY; CRYSTAL STRUCTURE; ENTEROVIRUS 71; FEMALE; HAND FOOT AND MOUTH DISEASE; IMMUNOGENICITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; VACCINE PRODUCTION; VIRUS EXAMINATION; VIRUS EXPRESSION; VIRUS MORPHOLOGY; VIRUS NEUTRALIZATION; VIRUS PURIFICATION;

ANIMALS; BACULOVIRIDAE; CRYOELECTRON MICROSCOPY; ENTEROVIRUS A, HUMAN; FEMALE; MICE; MICE, INBRED BALB C; MODELS, MOLECULAR; MOLECULAR CONFORMATION; NEUTRALIZATION TESTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPECIES SPECIFICITY; ULTRACENTRIFUGATION; VIRAL VACCINES; VIRION;

EID: 84899837750     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00200-14     Document Type: Article

References (56)

1. McMinn PC. 2002. An overview of the evolution of enterovirus 71 and its clinical and public health significance. FEMS Microbiol. Rev. 26:91-107. http://dx. doi. org/10. 1111/j. 1574-6976. 2002. tb00601. x.
2. Solomon T, Lewthwaite P, Perera D, Cardosa MJ, McMinn P, Ooi MH. 2010. Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect. Dis. 10:778-790. http://dx. doi. org/10. 1016/S1473-3099(10)70194-8.
3. Li YP, Liang ZL, Gao Q, Huang LR, Mao QY, Wen SQ, Liu Y, Yin WD, Li RC, Wang JZ. 2012. Safety and immunogenicity of a novel human Enterovirus 71 (EV71) vaccine: a randomized, placebo-controlled, double-blind, Phase I clinical trial. Vaccine 30:3295-3303. http://dx. doi. org/10. 1016/j. vaccine. 2012. 03. 010.
4. Rabenau HF, Richter M, Doerr HW. 2010. Hand, foot and mouth disease: seroprevalence of Coxsackie A16 and Enterovirus 71 in Germany. Med. Microbiol. Immunol. 199:45-51. http://dx. doi. org/10. 1007/s00430-009-0133-6.
5. Wang Y, Feng Z, Yang Y, Self S, Gao Y, Longini IM, Wakefield J, Zhang J, Wang L, Chen X, Yao L, Stanaway JD, Wang Z, Yang W. 2011. Hand, foot, and mouth disease in China: patterns of spread and transmissibility. Epidemiology 22:781-792. http://dx. doi. org/10. 1097/EDE. 0b013e318231d67a.
6. Yang F, Zhang T, Hu Y, Wang X, Du J, Li Y, Sun S, Sun X, Li Z, Jin Q. 2011. Survey of enterovirus infections from hand, foot and mouth disease outbreak in China, 2009. Virol. J. 8:508. http://dx. doi. org/10. 1186/1743-422X-8-508.
7. Xu W, Liu CF, Yan L, Li JJ, Wang LJ, Qi Y, Cheng RB, Xiong XY. 2012. Distribution of enteroviruses in hospitalized children with hand, foot and mouth disease and relationship between pathogens and nervous system complications. Virol. J. 9:8. http://dx. doi. org/10. 1186/1743-422X-9-8.
8. Cai Y, Liu Q, Huang X, Li D, Ku Z, Zhang Y, Huang Z. 2013. Active immunization with a Coxsackievirus A16 experimental inactivated vaccine induces neutralizing antibodies and protects mice against lethal infection. Vaccine 31:2215-2221. http://dx. doi. org/10. 1016/j. vaccine. 2013. 03. 007.
9. Cheng A, Fung CP, Liu CC, Lin YT, Tsai HY, Chang SC, Chou AH, Chang JY, Jiang RH, Hsieh YC, Su IJ, Chong PC, Hsieh SM. 2013. A Phase I, randomized, open-label study to evaluate the safety and immunogenicity of an enterovirus 71 vaccine. Vaccine 31:2471-2476. http://dx. doi. org/10. 1016/j. vaccine. 2013. 03. 015.
10. Hu YM, Wang X, Wang JZ, Wang L, Zhang YJ, Chang L, Liang ZL, Xia JL, Dai QG, Hu YL, Mao QY, Zhu FC, Song YF, Gao F, Chen JT. 2013. Immunogenicity, safety, and lot consistency of a novel inactivated enterovirus 71 vaccine in Chinese children aged 6 to 59 months. Clin. Vaccine Immunol. 20:1805-1811. http://dx. doi. org/10. 1128/CVI. 00491-13.
11. Li YP, Liang ZL, Xia JL, Wu JY, Wang L, Song LF, Mao QY, Wen SQ, Huang RG, Hu YS, Yao X, Miao X, Wu X, Li RC, Wang JZ, Yin WD. 2014. Immunogenicity, safety, and immune persistence of a novel inactivated human enterovirus 71 vaccine: a phase II, randomized, doubleblind, placebo-controlled trial. J. Infect. Dis. 209:46-55. http://dx. doi. org/10. 1093/infdis/jit429.
12. Liu CC, Lian WC, Butler M, Wu SC. 2007. High immunogenic enterovirus 71 strainandits production using serum-free microcarrierVerocell culture. Vaccine 25:19-24. http://dx. doi. org/10. 1016/j. vaccine. 2006. 06. 083.
13. Liu L, Zhang Y, Wang J, Zhao H, Jiang L, Che Y, Shi H, Li R, Mo Z, Huang T, Liang Z, Mao Q, Wang L, Dong C, Liao Y, Guo L, Yang E, Pu J, Yue L, Zhou Z, Li Q. 2013. Study of the integrated immune response induced by an inactivated EV71 vaccine. PLoS One 8:e54451. http://dx. doi. org/10. 1371/journal. pone. 0054451.
14. Mao Q, Cheng T, Zhu F, Li J, Wang Y, Li Y, Gao F, Yang L, Yao X, Shao J, Xia N, Liang Z, Wang J. 2013. The cross-neutralizing activity of enterovirus 71 subgenotype c4 vaccines in healthy Chinese infants and children. PLoS One 8:e79599. http://dx. doi. org/10. 1371/journal. pone. 0079599.
15. Meng FY, Li JX, Li XL, Chu K, Zhang YT, Ji H, Li L, Liang ZL, Zhu FC. 2012. Tolerability and immunogenicity of an inactivated enterovirus 71 vaccine in Chinese healthy adults and children: an open label, phase 1 clinical trial. Hum. Vaccin. Immunother. 8:668-674. http://dx. doi. org/10. 4161/hv. 19521.
16. Ong KC, Devi S, Cardosa MJ, Wong KT. 2010. Formaldehydeinactivated whole-virus vaccine protects a murine model of enterovirus 71 encephalomyelitis against disease. J. Virol. 84:661-665. http://dx. doi. org/10. 1128/JVI. 00999-09.
17. Wu SC, Liu CC, Lian WC. 2004. Optimization of microcarrier cell culture process for the inactivated enterovirus type 71 vaccine development. Vaccine 22:3858-3864. http://dx. doi. org/10. 1016/j. vaccine. 2004. 05. 037.
18. Zhu FC, Wang JZ, Li XL, Liang ZL, Ge HM, Meng FY, Mao QY, Zhang YT, Zhang ZY, Ji H, Gao F, Guo HJ, Zhu QY, Chu K, Wu X, Li JX, Chen QH, Chen XQ, Zhang WW, Hu YM, Li L, Li FX, Yao X, Liu P, Wang H, Shen XL. 2012. Reactogenicity and immunogenicity of an enterovirus 71 vaccine in Chinese healthy children and infants. Pediatr. Infect. Dis. J. 31:1158-1165. http://dx. doi. org/10. 1097/INF. 0b013e31826eba74.
19. Zhu F-C, Liang Z-L, Li X-L, Ge H-M, Meng F-Y, Mao Q-Y, Zhang Y-T, Hu Y-M, Zhang Z-Y, Li J-X, Gao F, Chen Q-H, Zhu Q-Y, Chu K, Wu X, Yao X, Guo H-J, Chen X-Q, Liu P, Dong Y-Y, Li F-X, Shen X-L, Wang J-Z. 2013. Immunogenicity and safety of an enterovirus 71 vaccine in healthy Chinese children and infants: a randomised, double-blind, placebo-controlled phase 2 clinical trial. Lancet 381:1037-1045. http://dx. doi. org/10. 1016/S0140-6736(12)61764-4.
20. Zhu F-C, Meng F-Y, Li J-X, Li X-L, Mao Q-Y, Tao H, Zhang Y-T, Yao X, Chu K, Chen Q-H, Hu Y-M, Wu X, Liu P, Zhu L-Y, Gao F, Jin H, Chen Y-J, Dong Y-Y, Liang Y-C, Shi N-M, Ge H-M, Liu L, Chen S-G, Ai X, Zhang Z-Y, Ji Y-G, Luo F-J, Chen X-Q, Zhang Y, Zhu L-W, Liang Z-L, Shen X-L. 2013. Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 381:2024-2032. http://dx. doi. org/10. 1016/S0140-6736(13)61049-1.
21. Zhu F, Xu W, Xia J, Liang Z, Liu Y, Zhang X, Tan X, Wang L, Mao Q, Wu J, Hu Y, Ji T, Song L, Liang Q, Zhang B, Gao Q, Li J, Wang S, Hu Y, Gu S, Zhang J, Yao G, Gu J, Wang X, Zhou Y, Chen C, Zhang M, Cao M, Wang J, Wang H, Wang N. 2014. Efficacy, safety, and immunogenicity of an enterovirus 71 vaccine in China. N. Engl. J. Med. 370:818-828. http://dx. doi. org/10. 1056/NEJMoa1304923.
22. Li R, Liu L, Mo Z, Wang X, Xia J, Liang Z, Zhang Y, Li Y, Mao Q, Wang J, Jiang L, Dong C, Che Y, Huang T, Jiang Z, Xie Z, Wang L, Liao Y, Liang Y, Nong Y, Liu J, Zhao H, Na R, Guo L, Pu J, Yang E, Sun L, Cui P, Shi H, Wang J, Li Q. 2014. An inactivated enterovirus 71 vaccine in healthy children. N. Engl. J. Med. 370:829-837. http://dx. doi. org/10. 1056/NEJMoa1303224.
23. Arita M, Nagata N, Iwata N, Ami Y, Suzaki Y, Mizuta K, Iwasaki T, Sata T, Wakita T, Shimizu H. 2007. An attenuated strain of enterovirus 71 belonging to genotype a showed a broad spectrum of antigenicity with attenuated neurovirulence in cynomolgus monkeys. J. Virol. 81:9386-9395. http://dx. doi. org/10. 1128/JVI. 02856-06.
24. Arita M, Shimizu H, Nagata N, Ami Y, Suzaki Y, Sata T, Iwasaki T, Miyamura T. 2005. Temperature-sensitive mutants of enterovirus 71 show attenuation in cynomolgus monkeys. J. Gen. Virol. 86:1391-1401. http://dx. doi. org/10. 1099/vir. 0. 80784-0.
25. Wu CN, Lin YC, Fann C, Liao NS, Shih SR, Ho MS. 2001. Protection against lethal enterovirus 71 infection in newborn mice by passive immunization with subunit VP1 vaccines and inactivated virus. Vaccine 20:895-904. http://dx. doi. org/10. 1016/S0264-410X(01)00385-1.
26. Chung CY, Chen CY, Lin SY, Chung YC, Chiu HY, Chi WK, Lin YL, Chiang BL, Chen WJ, Hu YC. 2010. Enterovirus 71 virus-like particle vaccine: improved production conditions for enhanced yield. Vaccine 28: 6951-6957. http://dx. doi. org/10. 1016/j. vaccine. 2010. 08. 052.
27. Chung YC, Ho MS, Wu JC, Chen WJ, Huang JH, Chou ST, Hu YC. 2008. Immunization with virus-like particles of enterovirus 71 elicits potent immune responses and protects mice against lethal challenge. Vaccine 26:1855-1862. http://dx. doi. org/10. 1016/j. vaccine. 2008. 01. 058.
28. Chung YC, Huang JH, Lai CW, Sheng HC, Shih SR, Ho MS, Hu YC. 2006. Expression, purification and characterization of enterovirus-71 virus-like particles. World J. Gastroenterol. 12:921-927. http://dx. doi. org/10. 3748/wjg. v12. i6. 921.
29. Hu YC, Hsu JT, Huang JH, Ho MS, Ho YC. 2003. Formation of enterovirus-like particle aggregates by recombinant baculoviruses coexpressing P1 and 3CD in insect cells. Biotechnol. Lett. 25:919-925. http://dx. doi. org/10. 1023/A:1024071514438.
30. Ku Z, Ye X, Huang X, Cai Y, Liu Q, Li Y, Su Z, Huang Z. 2013. Neutralizing antibodiesinducedbyrecombinantvirus-like particles of enterovirus71genotype C4 inhibit infection at pre-and post-attachment steps. PLoS One 8:e57601. http://dx. doi. org/10. 1371/journal. pone. 0057601.
31. Li HY, Han JF, Qin CF, Chen R. 2013. Virus-like particles for enterovirus 71 produced from Saccharomyces cerevisiae potently elicits protective immune responses in mice. Vaccine 31:3281-3287. http://dx. doi. org/10. 1016/j. vaccine. 2013. 05. 019.
32. Lin YL, Yu CI, Hu YC, Tsai TJ, Kuo YC, Chi WK, Lin AN, Chiang BL. 2012. Enterovirus type 71 neutralizing antibodies in the serum of macaque monkeys immunized with EV71 virus-like particles. Vaccine 30:1305-1312. http://dx. doi. org/10. 1016/j. vaccine. 2011. 12. 081.
33. Liu Q, Yan K, Feng Y, Huang X, Ku Z, Cai Y, Liu F, Shi J, Huang Z. 2012. A virus-like particle vaccine for coxsackievirus A16 potently elicits neutralizing antibodies that protect mice against lethal challenge. Vaccine 30:6642-6648. http://dx. doi. org/10. 1016/j. vaccine. 2012. 08. 071.
34. Zhao H, Li HY, Han JF, Deng YQ, Li YX, Zhu SY, He YL, Qin ED, Chen R, Qin CF. 2013. Virus-like particles produced in Saccharomyces cerevisiae elicit protective immunity against coxsackievirus A16 in mice. Appl. Microbiol. Biotechnol. 97:10445-10452. http://dx. doi. org/10. 1007/s00253-013-5257-3.
35. Foo DG, Alonso S, Phoon MC, Ramachandran NP, Chow VT, Poh CL. 2007. Identification of neutralizing linear epitopes from the VP1 capsid protein of Enterovirus 71 using synthetic peptides. Virus Res. 125:61-68. http://dx. doi. org/10. 1016/j. virusres. 2006. 12. 005.
36. Kirk K, Poh CL, Fecondo J, Pourianfar H, Shaw J, Grollo L. 2012. Cross-reactive neutralizing antibody epitopes against Enterovirus 71 identified by an in silico approach. Vaccine 30:7105-7110. http://dx. doi. org/10. 1016/j. vaccine. 2012. 09. 030.
37. Liu CC, Chou AH, Lien SP, Lin HY, Liu SJ, Chang JY, Guo MS, Chow YH, Yang WS, Chang KH, Sia C, Chong P. 2011. Identification and characterization of a cross-neutralization epitope of Enterovirus 71. Vaccine 29:4362-4372. http://dx. doi. org/10. 1016/j. vaccine. 2011. 04. 010.
38. Shi J, Huang X, Liu Q, Huang Z. 2013. Identification of conserved neutralizing linear epitopes within the VP1 protein of coxsackievirus A16. Vaccine 31:2130-2136. http://dx. doi. org/10. 1016/j. vaccine. 2013. 02. 051.
39. Ye X, Ku Z, Liu Q, Wang X, Shi J, Zhang Y, Kong L, Cong Y, Huang Z. 2014. Chimeric virus-like particle vaccines displaying conserved enterovirus 71 epitopes elicit protective neutralizing antibodies in mice through divergent mechanisms. J. Virol. 88:72-81. http://dx. doi. org/10. 1128/JVI. 01848-13.
40. Ren J, Wang X, Hu Z, Gao Q, Sun Y, Li X, Porta C, Walter TS, Gilbert RJ, Zhao Y, Axford D, Williams M, McAuley K, Rowlands DJ, Yin W, Wang J, Stuart DI, Rao Z, Fry EE. 2013. Picornavirus uncoating intermediate captured in atomic detail. Nat. Commun. 4:1929. http://dx. doi. org/10. 1038/ncomms2889.
41. Wang X, Peng W, Ren J, Hu Z, Xu J, Lou Z, Li X, Yin W, Shen X, Porta C, Walter TS, Evans G, Axford D, Owen R, Rowlands DJ, Wang J, Stuart DI, Fry EE, Rao Z. 2012. A sensor-adaptor mechanism for enterovirus uncoating from structures of EV71. Nat. Struct. Mol. Biol. 19:424-429. http://dx. doi. org/10. 1038/nsmb. 2255.
42. Schuck P, Rossmanith P. 2000. Determination of the sedimentation coefficient distribution by least-squares boundary modeling. Biopolymers 54:328-341. http://dx. doi. org/10. 1002/1097-0282(20001015)54:5<328::AID-BIP40>3. 0. CO;2-P.
43. Brown PH, Schuck P. 2006. Macromolecular size-and-shape distributions by sedimentation velocity analytical ultracentrifugation. Biophys. J. 90:4651-4661. http://dx. doi. org/10. 1529/biophysj. 106. 081372.
44. Suloway C, Pulokas J, Fellmann D, Cheng A, Guerra F, Quispe J, Stagg S, Potter CS, Carragher B. 2005. Automated molecular microscopy: the new Leginon system. J. Struct. Biol. 151:41-60. http://dx. doi. org/10. 1016/j. jsb. 2005. 03. 010.
45. Roseman A. 2004. Find EM-a fast, efficient program for automatic selection of particles from electron micrographs. J. Struct. Biol. 145:91-99. http://dx. doi. org/10. 1016/j. jsb. 2003. 11. 007.
46. Lander GC, Stagg SM, Voss NR, Cheng A, Fellmann D, Pulokas J, Yoshioka C, Irving C, Mulder A, Lau P-W, Lyumkis D, Potter CS, Carragher B. 2009. Appion: an integrated, database-driven pipeline to facilitate EM image processing. J. Struct. Biol. 166:95-102. http://dx. doi. org/10. 1016/j. jsb. 2009. 01. 002.
47. Ludtke SJ, Baldwin PR, Chiu W. 1999. EMAN: semiautomated software for high-resolution single-particle reconstructions. J. Struct. Biol. 128:82-97. http://dx. doi. org/10. 1006/jsbi. 1999. 4174.
48. Liang Y, Ke EY, Zhou ZH. 2002. IMIRS: a high-resolution 3D reconstruction package integrated with a relational image database. J. Struct. Biol. 137:292-304. http://dx. doi. org/10. 1016/S1047-8477(02)00014-X.
49. Tang G, Peng L, Baldwin PR, Mann DS, Jiang W, Rees I, Ludtke SJ. 2007. EMAN2: an extensible image processing suite for electron microscopy. J. Struct. Biol. 157:38-46. http://dx. doi. org/10. 1016/j. jsb. 2006. 05. 009.
50. Unser M, Trus BL, Steven AC. 1987. A new resolution criterion based on spectral signal-to-noise ratios. Ultramicroscopy 23:39-51. http://dx. doi. org/10. 1016/0304-3991(87)90225-7.
51. Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, Ferrin TE. 2004. UCSF Chimera-a visualization system for exploratory research and analysis. J. Comput. Chem. 25:1605-1612. http://dx. doi. org/10. 1002/jcc. 20084.
52. Plevka P, Perera R, Cardosa J, Kuhn RJ, Rossmann MG. 2012. Crystal structure of human enterovirus 71. Science 336:1274. http://dx. doi. org/10. 1126/science. 1218713.
53. Shingler KL, Yoder JL, Carnegie MS, Ashley RE, Makhov AM, Conway JF, Hafenstein S. 2013. The enterovirus 71 A-particle forms a gateway to allow genome release: a cryoEM study of picornavirus uncoating. PLoS Pathog. 9:e1003240. http://dx. doi. org/10. 1371/journal. ppat. 1003240.
54. Cifuente JO, Lee H, Yoder JD, Shingler KL, Carnegie MS, Yoder JL, Ashley RE, Makhov AM, Conway JF, Hafenstein S. 2013. Structures of the procapsid and mature virion of enterovirus 71 strain 1095. J. Virol. 87:7637-7645. http://dx. doi. org/10. 1128/JVI. 03519-12.
55. Gong MQ, Zhou J, Yang CT, Deng Y, Zhao GY, Zhang YH, Wang Y, Zhou YS, Tan WJ, Xu HL. 2012. Insect cell-expressed hemagglutinin with CpG oligodeoxynucleotides plus alum as an adjuvant is a potential pandemic influenza vaccine candidate. Vaccine 30:7498-7505. http://dx. doi. org/10. 1016/j. vaccine. 2012. 10. 054.
56. Bubeck D, Filman DJ, Cheng N, Steven AC, Hogle JM, Belnap DM. 2005. The structure of the poliovirus 135S cell entry intermediate at 10-angstrom resolution reveals the location of an externalized polypeptide that binds to membranes. J. Virol. 79:7745-7755. http://dx. doi. org/10. 1128/JVI. 79. 12. 7745-7755. 2005.